Identification of Mad as a repressor of the human telomerase (hTERT) gene

被引:139
作者
Oh, S
Song, YH
Yim, J
Kim, TK [1 ]
机构
[1] Harvard Univ, Sch Med, Inst Chem & Cell Biol, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Seoul Natl Univ, Natl Creat Res Initiat, Inst Mol Biol & Genet, Ctr Genet Reprogramming, Seoul 151742, South Korea
关键词
telomerase; hTERT; Myc; Mad; repression;
D O I
10.1038/sj.onc.1203439
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of telomerase, which has been frequently associated with cellular immortality, may constitute a key step in the development of human cancer. Derepression in the expression of its catalytic subunit hTERT gene has been proposed to directly link to the telomerase activation in tumor cells. Little is known about the mechanism how the hTERT gene is repressed in telomerase-negative mortal cells. This study was conducted, using an expression cloning approach, with the aim of identifying the gene(s) responsible for repressing the hTERT gene expression. Using this genetic screen, we isolated the transcription factor Mad as a repressor. Mutation of its DNA binding sites caused significant de-repression of hTERT promoter activity in mortal cells. This Mad-mediated repression of the hTERT promoter in mortal cells was counteracted by ectopic expression of Myc, The antagonism between Mad and Myc was also observed with an endogenous hTERT promoter. Their potential roles in differential hTERT promoter activities were further supported by the relative amounts of Mad and Myc proteins detected in immortal and mortal cells. Thus, Mad may be a direct negative regulator of hTERT in mortal cells and this repression mechanism can be inhibited by induction of Myc in immortal cells.
引用
收藏
页码:1485 / 1490
页数:6
相关论文
共 34 条
  • [1] MAD - A HETERODIMERIC PARTNER FOR MAX THAT ANTAGONIZES MYC TRANSCRIPTIONAL ACTIVITY
    AYER, DE
    KRETZNER, L
    EISENMAN, RN
    [J]. CELL, 1993, 72 (02) : 211 - 222
  • [2] MYC AND MAX ASSOCIATE INVIVO
    BLACKWOOD, EM
    LUSCHER, B
    EISENMAN, RN
    [J]. GENES & DEVELOPMENT, 1992, 6 (01) : 71 - 80
  • [3] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [4] The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation
    Cole, MD
    McMahon, SB
    [J]. ONCOGENE, 1999, 18 (19) : 2916 - 2924
  • [5] The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter
    Cong, YS
    Wen, JP
    Bacchetti, S
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (01) : 137 - 142
  • [6] Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells
    Cuthbert, AP
    Bond, J
    Trott, DA
    Gill, S
    Broni, J
    Marriott, A
    Khoudoli, G
    Parkinson, EK
    Cooper, CS
    Newbold, RF
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (01): : 37 - 45
  • [7] Dang CV, 1999, MOL CELL BIOL, V19, P1
  • [8] Myc target genes
    Grandori, C
    Eisenman, RN
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (05) : 177 - 181
  • [9] Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
    Greenberg, RA
    O'Hagan, RC
    Deng, HY
    Xiao, QR
    Hann, SR
    Adams, RR
    Lichtsteiner, S
    Chin, L
    Morin, GB
    DePinho, RA
    [J]. ONCOGENE, 1999, 18 (05) : 1219 - 1226
  • [10] Telomerase activity, cell proliferation, and cancer
    Greider, CW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) : 90 - 92